# Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy Volunteers

> **NCT02786082** · PHASE1 · COMPLETED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 29 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** 20mg Azilsartan Tablets
- **DRUG:** 40mg Azilsartan Tablets

## Key facts

- **NCT ID:** NCT02786082
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-01
- **Primary completion:** 2017-08-31
- **Final completion:** 2017-11-30
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2018-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02786082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02786082, "Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy Volunteers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02786082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*